Enzo Net Tangible Assets vs Current Deferred Revenue Analysis

ENZ Stock

USD 1.08 0.05 4.85%

Enzo Biochem financial indicator trend analysis is much more than just examining Enzo Biochem latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Enzo Biochem is a good investment. Please check the relationship between Enzo Biochem Net Tangible Assets and its Current Deferred Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Net Tangible Assets vs Current Deferred Revenue

Net Tangible Assets vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Enzo Biochem Net Tangible Assets account and Current Deferred Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Enzo Biochem's Net Tangible Assets and Current Deferred Revenue is -0.45. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Enzo Biochem, assuming nothing else is changed. The correlation between historical values of Enzo Biochem's Net Tangible Assets and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Enzo Biochem are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Net Tangible Assets i.e., Enzo Biochem's Net Tangible Assets and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-0.45

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Enzo Biochem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Enzo Biochem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.At this time, Enzo Biochem's Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 54.7 M in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	42.0M	11.6M	14.6M	13.9M
Total Revenue	107.1M	31.1M	31.9M	63.1M

Gross Profit Total Revenue

Enzo Biochem fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Common Stock Total Equity	Common Stock
Total Assets		0.05	0.25	0.32	0.83	0.49	-0.54	-0.15	0.67	0.21	-0.1	0.81	-0.18	0.47	0.02	0.14	0.26	0.3	0.23	0.42	0.9	-0.59	0.01	0.1	0.42	0.47
Short Long Term Debt Total	0.05		-0.27	-0.24	-0.44	0.41	0.55	0.66	-0.05	0.46	0.79	0.02	-0.55	-0.55	0.97	-0.14	-0.03	-0.62	0.86	0.23	-0.14	-0.45	-0.38	0.36	-0.57	-0.58
Other Current Liab	0.25	-0.27		0.51	0.19	0.11	-0.41	-0.36	0.3	-0.19	-0.25	0.3	-0.49	0.26	-0.26	0.01	0.48	0.2	0.05	0.4	0.27	0.33	-0.48	-0.07	0.35	0.36
Total Current Liabilities	0.32	-0.24	0.51		0.18	0.51	-0.11	-0.71	0.02	0.42	-0.6	0.06	0.12	0.74	-0.42	0.51	0.2	0.75	0.26	0.44	0.18	0.19	0.2	0.51	0.7	0.73
Total Stockholder Equity	0.83	-0.44	0.19	0.18		0.11	-0.77	-0.33	0.65	-0.12	-0.39	0.72	0.17	0.57	-0.43	0.1	0.16	0.46	-0.34	0.12	0.87	-0.38	0.25	-0.2	0.53	0.58
Property Plant And Equipment Net	0.49	0.41	0.11	0.51	0.11		0.36	-0.35	-0.17	0.87	-0.14	-0.01	-0.28	0.45	0.27	0.67	0.54	0.36	0.63	0.82	0.1	-0.3	-0.08	0.63	0.43	0.44
Net Debt	-0.54	0.55	-0.41	-0.11	-0.77	0.36		0.14	-0.86	0.61	0.25	-0.78	-0.05	-0.34	0.49	0.35	0.0	-0.25	0.44	0.16	-0.8	0.1	-0.02	0.49	-0.35	-0.37
Retained Earnings	-0.15	0.66	-0.36	-0.71	-0.33	-0.35	0.14		0.24	-0.24	0.95	0.22	-0.38	-0.86	0.77	-0.63	-0.44	-0.9	0.33	-0.38	-0.01	-0.33	-0.34	-0.27	-0.88	-0.9
Cash	0.67	-0.05	0.3	0.02	0.65	-0.17	-0.86	0.24		-0.43	0.19	0.95	-0.25	0.11	0.0	-0.48	-0.05	-0.04	0.01	-0.05	0.88	-0.41	-0.18	-0.36	0.1	0.11
Non Current Assets Total	0.21	0.46	-0.19	0.42	-0.12	0.87	0.61	-0.24	-0.43		-0.08	-0.3	0.0	0.28	0.28	0.72	0.16	0.3	0.6	0.55	-0.19	-0.18	0.22	0.74	0.18	0.22
Non Currrent Assets Other	-0.1	0.79	-0.25	-0.6	-0.39	-0.14	0.25	0.95	0.19	-0.08		0.19	-0.55	-0.8	0.88	-0.51	-0.27	-0.87	0.52	-0.15	-0.04	-0.38	-0.5	-0.19	-0.8	-0.83
Cash And Short Term Investments	0.81	0.02	0.3	0.06	0.72	-0.01	-0.78	0.22	0.95	-0.3	0.19		-0.28	0.16	0.07	-0.37	0.0	-0.02	0.11	0.03	0.96	-0.56	-0.17	-0.25	0.15	0.16
Net Receivables	-0.18	-0.55	-0.49	0.12	0.17	-0.28	-0.05	-0.38	-0.25	0.0	-0.55	-0.28		0.35	-0.63	0.16	-0.54	0.5	-0.54	-0.55	-0.12	0.07	0.92	0.15	0.25	0.28
Common Stock Shares Outstanding	0.47	-0.55	0.26	0.74	0.57	0.45	-0.34	-0.86	0.11	0.28	-0.8	0.16	0.35		-0.66	0.62	0.34	0.97	-0.17	0.39	0.39	-0.02	0.38	0.21	0.98	0.99
Non Current Liabilities Total	0.02	0.97	-0.26	-0.42	-0.43	0.27	0.49	0.77	0.0	0.28	0.88	0.07	-0.63	-0.66		-0.26	0.01	-0.76	0.76	0.18	-0.11	-0.45	-0.51	0.17	-0.65	-0.67
Inventory	0.14	-0.14	0.01	0.51	0.1	0.67	0.35	-0.63	-0.48	0.72	-0.51	-0.37	0.16	0.62	-0.26		0.38	0.66	0.1	0.62	-0.15	0.19	0.26	0.28	0.56	0.58
Other Current Assets	0.26	-0.03	0.48	0.2	0.16	0.54	0.0	-0.44	-0.05	0.16	-0.27	0.0	-0.54	0.34	0.01	0.38		0.2	0.1	0.84	0.08	0.11	-0.56	-0.02	0.47	0.44
Other Stockholder Equity	0.3	-0.62	0.2	0.75	0.46	0.36	-0.25	-0.9	-0.04	0.3	-0.87	-0.02	0.5	0.97	-0.76	0.66	0.2		-0.26	0.27	0.22	0.14	0.53	0.25	0.92	0.94
Total Liab	0.23	0.86	0.05	0.26	-0.34	0.63	0.44	0.33	0.01	0.6	0.52	0.11	-0.54	-0.17	0.76	0.1	0.1	-0.26		0.47	0.01	-0.35	-0.36	0.53	-0.2	-0.2
Property Plant And Equipment Gross	0.42	0.23	0.4	0.44	0.12	0.82	0.16	-0.38	-0.05	0.55	-0.15	0.03	-0.55	0.39	0.18	0.62	0.84	0.27	0.47		0.12	0.02	-0.46	0.21	0.43	0.44
Total Current Assets	0.9	-0.14	0.27	0.18	0.87	0.1	-0.8	-0.01	0.88	-0.19	-0.04	0.96	-0.12	0.39	-0.11	-0.15	0.08	0.22	0.01	0.12		-0.54	-0.01	-0.21	0.36	0.39
Intangible Assets	-0.59	-0.45	0.33	0.19	-0.38	-0.3	0.1	-0.33	-0.41	-0.18	-0.38	-0.56	0.07	-0.02	-0.45	0.19	0.11	0.14	-0.35	0.02	-0.54		-0.09	-0.18	0.02	0.01
Accounts Payable	0.01	-0.38	-0.48	0.2	0.25	-0.08	-0.02	-0.34	-0.18	0.22	-0.5	-0.17	0.92	0.38	-0.51	0.26	-0.56	0.53	-0.36	-0.46	-0.01	-0.09		0.33	0.25	0.29
Short Term Debt	0.1	0.36	-0.07	0.51	-0.2	0.63	0.49	-0.27	-0.36	0.74	-0.19	-0.25	0.15	0.21	0.17	0.28	-0.02	0.25	0.53	0.21	-0.21	-0.18	0.33		0.16	0.18
Common Stock Total Equity	0.42	-0.57	0.35	0.7	0.53	0.43	-0.35	-0.88	0.1	0.18	-0.8	0.15	0.25	0.98	-0.65	0.56	0.47	0.92	-0.2	0.43	0.36	0.02	0.25	0.16		0.99
Common Stock	0.47	-0.58	0.36	0.73	0.58	0.44	-0.37	-0.9	0.11	0.22	-0.83	0.16	0.28	0.99	-0.67	0.58	0.44	0.94	-0.2	0.44	0.39	0.01	0.29	0.18	0.99

Click cells to compare fundamentals

Enzo Biochem Account Relationship Matchups

Enzo Biochem fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	112.5M	113.7M	95.9M	121.9M	85.8M	100.6M
Short Long Term Debt Total	32.8M	22.7M	20.6M	7.0M	3.5M	3.3M
Other Current Liab	10.3M	8.1M	8.2M	34.5M	22.5M	23.6M
Total Current Liabilities	32.8M	26.1M	24.6M	40.0M	24.8M	15.1M
Total Stockholder Equity	58.4M	68.6M	54.5M	78.5M	56.1M	74.8M
Property Plant And Equipment Net	34.4M	33.6M	32.4M	16.7M	15.2M	12.5M
Net Debt	(15.1M)	9.2M	(1.0M)	(75.4M)	(48.9M)	(46.4M)
Retained Earnings	(278.3M)	(270.4M)	(288.6M)	(268.4M)	(294.4M)	(279.7M)
Cash	47.9M	13.5M	21.6M	82.4M	52.4M	42.5M
Non Current Assets Total	43.8M	43.1M	41.5M	23.4M	15.7M	14.9M
Non Currrent Assets Other	1.4M	1.8M	1.6M	1.7M	530K	503.5K
Cash And Short Term Investments	47.9M	43.5M	21.6M	82.4M	52.4M	46.6M
Net Receivables	9.1M	10.2M	4.8M	4.8M	4.0M	3.8M
Common Stock Shares Outstanding	47.7M	48.3M	48.6M	49.2M	50.9M	37.4M
Liabilities And Stockholders Equity	112.5M	113.7M	95.9M	121.9M	85.8M	100.6M
Non Current Liabilities Total	21.4M	19.0M	16.8M	3.4M	4.9M	7.8M
Inventory	7.8M	12.7M	15.4M	7.9M	6.8M	5.6M
Other Current Assets	4.0M	4.2M	6.9M	3.3M	6.8M	7.2M
Other Stockholder Equity	334.5M	337.1M	339.5M	344.4M	348.1M	220.0M
Total Liab	54.2M	45.1M	41.4M	43.4M	29.7M	18.8M
Property Plant And Equipment Gross	34.4M	33.6M	63.9M	34.0M	32.0M	33.6M
Total Current Assets	68.8M	70.6M	54.4M	98.5M	70.0M	68.6M
Accumulated Other Comprehensive Income	1.7M	1.4M	3.2M	1.9M	1.9M	2.0M
Intangible Assets	1.0M	538K	244K	7.5M	6.7M	6.7M
Accounts Payable	8.5M	8.1M	3.7M	3.6M	1.4M	1.3M
Short Term Debt	11.5M	7.2M	1.1M	2.0M	917K	871.2K
Common Stock Total Equity	476K	479K	485K	487K	560.1K	422.6K
Common Stock	479K	485K	487K	499K	521K	433.3K
Other Assets	1.4M	1.8M	1.6M	6.7M	6.0M	6.3M
Property Plant Equipment	14.5M	33.6M	17.3M	16.7M	19.2M	10.2M
Current Deferred Revenue	(391K)	2.5M	2.7M	11.7M	5.9M	3.7M
Long Term Debt	4.5M	4.4M	4.1M	269K	189K	179.6K
Net Tangible Assets	50.4M	60.9M	47.0M	78.5M	90.2M	58.6M
Retained Earnings Total Equity	(252.2M)	(249.7M)	(278.3M)	(288.6M)	(259.8M)	(272.8M)
Capital Surpluse	334.5M	337.1M	339.5M	344.4M	396.1M	359.7M
Non Current Liabilities Other	424K	16.9M	5K	12.8M	14.7M	15.4M
Short Long Term Debt	7.1M	152K	229K	2.6M	76K	72.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Enzo Net Tangible Assets vs Current Deferred Revenue Analysis

Net Tangible Assets vs Current Deferred Revenue

Net Tangible Assets vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Net Tangible Assets

Current Deferred Revenue

Enzo Biochem fundamental ratios Correlations

Enzo Biochem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Enzo Biochem fundamental ratios Accounts

Also Currently Popular

Additional Tools for Enzo Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Common Stock Total Equity
Common Stock Total Equity	+ 0.98	Common Stock Shares Outstanding
Non Current Liabilities Total	+ 0.97	Short Long Term Debt Total
Other Stockholder Equity	+ 0.97	Common Stock Shares Outstanding
Total Current Assets	+ 0.96	Cash And Short Term Investments

Common Stock	- 0.9	Retained Earnings
Other Stockholder Equity	- 0.9	Retained Earnings
Common Stock Total Equity	- 0.88	Retained Earnings
Other Stockholder Equity	- 0.87	Non Currrent Assets Other
Common Stock Shares Outstanding	- 0.86	Retained Earnings
Cash	- 0.86	Net Debt